Particle.news

Download on the App Store

Doctors Weigh In on 'Ozempic Vulva' Reports as Cosmetic Consults Rise

Clinicians say vulvar changes described online likely reflect fat loss and skin laxity from rapid weight reduction, not a proven drug effect.

Overview

  • Recent tabloid and social posts feature women on GLP-1 drugs reporting loss of labial volume, a deflated appearance, dryness, altered discharge, and pelvic weakness.
  • OB-GYN Sherry Ross says rapid weight loss can cause skin laxity throughout the body, including the pubic mons and inner and outer labia.
  • Clinicians report more requests for vaginal rejuvenation, with options such as labia puffing using dermal fillers or fat grafting, labiaplasty, and vaginal tightening.
  • Los Angeles OB-GYN Michael Tahery notes filler results may last up to eight months, and Australian plastic surgeon Justin Perron says he now sees several such consultations each week.
  • Indian experts caution there is no direct evidence linking semaglutide to vaginal dryness and note weight loss can improve incontinence, urging medically supervised care and evaluation for any concerning changes.